Home›Companies›Biotech & Pharma›OncoVerity

OncoVerity, Inc.

Updated Oct 27, 2026·Latest SEC filing Dec 10, 2024·Suggest an edit

About OncoVerity

OncoVerity is a private company based in Aurora, Colorado, incorporated in 2022 in Delaware. It has reported $18,000,000 raised in two offerings on Form D since August 2022. Its chief executive is Massimiliano Colao.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Nov 25, 2024Dec 10, 2024$14,000,000of $42.0M target2$7.0MEquityRule 506(b)Form D ↗
Jul 26, 2022Aug 22, 2022$4,000,000of $30.0M target2$2.0MEquityRule 506(b)Form D ↗
Total, two offerings$18,000,000

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on OncoVerity's Form D filed Dec 10, 2024.

MC
Massimiliano Colao
Chief Executive Officer and director
AL
Arjen Lemmen
Director
KM
SH
Steven Hess
Director
CS
Clayton Smith
Chief Medical Officer

Earlier filings also listed Steven VanNurden (chief executive officer and director, last listed Aug 2022).

Sources

  1. SECOncoVerity, Inc. filing history